Efficacy and safety of immunotherapy in elderly patients with advanced non-small cell lung cancer: a real-world study stratified by age

Abstract Objective This study aimed to evaluate the efficacy and safety of immunotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC), stratified by age. Methods A retrospective analysis included elderly patients (≥ 65 years) diagnosed with stage III–IV NSCLC who received imm...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Yi Dong, Mei-cen Liu, Yun-ye Mao, Yi-heng Lu, An Wang, Xin Zhou, Yin-min Ji, Shu-yan Xiao, Ya-hui Lv, Tao Li, Xiao-ran Cui, Yi Hu
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	BMC 2026-03-01
Rangatū:	BMC Geriatrics
Ngā marau:	Elderly patients Advanced non-small cell lung cancer Immunotherapy Adverse events
Urunga tuihono:	https://doi.org/10.1186/s12877-026-07248-6
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!